The recent shortage of erythromycin ophthalmic ointment has compelled pediatricians to choose alternative therapies for ophthalmia neonatorum prophylaxis. The Cincinnati Children's Division of Neonatology, which staffs nine regional nurseries, recommended substitution of gentamicin ophthalmic ointment (0.3%) after supplies of erythromycin ointment were exhausted. This decision was based on reports of efficacy, 1,2 cost analysis and the recommendations of the Centers for Disease Control.
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Gentamicin ophthalmic ointment was in use for 2 days at two hospitals when several infants showed periorbital skin irritation with erythema and edema of the eye lid ( Figure 1 ). The sclera and cornea appeared unaffected and the dermatitis resolved without any specific intervention.
Erythromycin ointment contains only mineral oil and petroleum jelly. Gentamicin ointment contains the preservatives methylparaben and propylparaben, which are esters of parahydroxybenzoic acid. Although there are no published reports of skin reaction to gentamicin ophthalmic ointment, use for ophthalmia neonatorum prophylaxis is presumably novel. Within 48 h of identifying the first adverse reaction, we substituted tobramycin ophthalmic solution, which provides the same bacterial coverage and cost savings. This preparation contains the preservative benzalkonium chloride, a quaternary ammonium cationic surfactant, and has not generated any periorbital skin irritation to date.
This change in ophthalmia neonatorum prophylaxis, necessitated by a pharmacological shortage, has the potential to affect a large number of infants. In this case, the dermatitis associated with the use of gentamicin ophthalmic ointment was self-limiting and without apparent sequelae. However, this episode reminds us that apparently benign medications may cause potential harm in the vulnerable neonatal population. Our regionalized clinical model allowed us to quickly identify an adverse drug reaction and facilitated prompt discontinuation of this medication. The collaboration and communication between nine area hospitals also helped us to share our experience and to prevent the exposure of many other infants to this medication, thus preventing unnecessary harm. 
